[Techniques for occlusion of the left atrial appendage: chances and risks]

Area of Science:

• Cardiology
• Neurology
• Medical Devices

Context:

• Atrial fibrillation is a major cause of ischemic stroke, accounting for 15-20% of cases.
• Warfarin is a standard stroke prevention therapy for atrial fibrillation but has contraindications for many patients due to bleeding risks.
• A significant percentage (14-44%) of high-risk patients cannot receive anticoagulation therapy.

Purpose:

• To evaluate left atrial appendage (LAA) occlusion as an alternative stroke prevention strategy.
• To compare the efficacy and safety of LAA occlusion versus warfarin therapy in non-valvular atrial fibrillation patients.
• To assess percutaneous transcatheter approaches for LAA occlusion.

Summary:

• Left atrial appendage (LAA) occlusion is emerging as a viable alternative to anticoagulation for stroke prevention in atrial fibrillation.
• Percutaneous transcatheter LAA occlusion techniques have been developed, offering a less invasive option.
• Recent studies suggest that mechanical LAA occlusion is non-inferior to warfarin in preventing thromboembolic events.

Impact:

• Provides a crucial therapeutic option for atrial fibrillation patients at high risk of stroke but ineligible for anticoagulation.
• Reduces the incidence of ischemic strokes and associated morbidity/mortality in selected patient populations.
• Advances interventional cardiology by offering a minimally invasive alternative to long-term oral anticoagulation.